Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.39 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10340185 | 0.93 | ALDH1A1 (0.40) | ALDH1A1LMNAKMT2AMAPTEHMT2 | |
| SCHEMBL10340287 | 0.92 | HDAC1 (0.41) | ALDH1A1LMNAKMT2AMAPTEHMT2 | |
| SCHEMBL10340513 | 0.91 | HDAC1 (0.42) | ALDH1A1LMNAKMT2AMAPTEHMT2 | |
| SCHEMBL28707482 | 0.87 | ALDH1A1 (0.57) | ALDH1A1LMNAKMT2AMAPTRAB9A | |
| SCHEMBL29430092 | 0.87 | ALDH1A1 (0.36) | ALDH1A1LMNAKMT2AMAPTEHMT2 | |
| SCHEMBL42368 | 0.86 | ALDH1A1 (0.44) | ALDH1A1LMNAKMT2AMAPTEHMT2 | |
| SCHEMBL29352062 | 0.86 | ALDH1A1 (0.44) | ALDH1A1LMNAKMT2AMAPTEHMT2 | |
| SCHEMBL13252991 | 0.83 | ALDH1A1 (0.43) | ALDH1A1LMNAKMT2AMAPTEHMT2 | |
| SCHEMBL18562069 | 0.82 | ALDH1A1 (0.40) | ALDH1A1LMNAKMT2AMAPTEHMT2 | |
| SCHEMBL12533282 | 0.82 | ALDH1A1 (0.40) | ALDH1A1LMNAKMT2AMAPTEHMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113039191-B | Nucleotide analogues | 奇异基因组学系统公司 | 2024-07-16 | — | — | CN | disclosed |
| US-11634497-B2 | Anti-CCR7 antibody drug conjugates | NOVARTIS AG (CH) | 2023-04-25 | — | — | US | disclosed |
| US-20200216548-A1 | ANTI-CCR7 ANTIBODY DRUG CONJUGATES | NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC. DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION | 2020-07-09 | — | — | US | disclosed |
| US-8084247-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2011-12-27 | — | — | US | disclosed |
| US-8084247-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2011-12-27 | — | — | US | disclosed |
| US-8039251-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2011-10-18 | — | — | US | disclosed |
| US-8039251-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2011-10-18 | — | — | US | disclosed |
| US-7960169-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2011-06-14 | — | — | US | disclosed |
| US-7960169-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2011-06-14 | — | — | US | disclosed |
| US-7741107-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2010-06-22 | — | — | US | disclosed |
| US-20100143930-A1 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2010-06-10 | — | — | US | disclosed |
| US-20100143930-A1 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2010-06-10 | — | — | US | disclosed |
| US-7416883-B2 | Biological indicator | STERIS INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-7416883-B2 | Biological indicator | STERIS INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-20080199903-A1 | Biological indicator | STERIS INC. (US) | 2008-08-21 | — | — | US | disclosed |
| US-20080199903-A1 | Biological indicator | STERIS INC. (US) | 2008-08-21 | — | — | US | disclosed |
| EP-0196007-B1 | DESMOSINE DERIVATIVES AND REAGENT FOR PREPARING ARTIFICIAL ANTIGENS | JAPAN TOBACCO INC. (JP) | 1990-01-10 | — | — | EP | disclosed |
| US-4841055-A | Desmosine derivatives and reagent for preparing artificial antigens | JAPAN TOBACCO INC. (JP) | 1989-06-20 | — | — | US | disclosed |
| US-4723012-A | Desmosine derivatives having a disulfide bond and preparation of artificial antigen using the same | JAPAN TOBACCO INC. (JP) | 1988-02-02 | — | — | US | disclosed |
| EP-0196007-A2 | Desmosine derivatives and reagent for preparing artificial antigens | JAPAN TOBACCO INC. (JP) | 1986-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200216548-A1 | ANTI-CCR7 ANTIBODY DRUG CONJUGATES | CCR7, CXCR3, CXCR4 | ALDH1A1 2197/4885LMNA 2182/4885KMT2A 2497/4885 |
| US-11634497-B2 | Anti-CCR7 antibody drug conjugates | CCR7, CXCR3, CXCR4 | ALDH1A1 2197/4885LMNA 2182/4885KMT2A 2497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.